Nanogels with specialized peptides enhance antibiotic delivery, effectively treating recurrent urinary tract infections at the source.

Nanogels with specialized peptides enhance antibiotic delivery, effectively treating recurrent urinary tract infections at the source.

The FDA approval is based on late-stage data, which shows that GSK's Blujepa is at least as effective as a leading standard treatment for...

Researchers have developed a novel combination of materials that have organic and inorganic properties, with the goal of using them in technologies...

Researchers have developed a novel combination of materials that have organic and inorganic properties, with the goal of using them in technologies...

Discover less invasive alternatives to traditional bladder tests for urinary incontinence, offering more comfort and accurate diagnosis options.

Discover less invasive alternatives to traditional bladder tests for urinary incontinence, offering more comfort and accurate diagnosis options.

TUESDAY, March 25, 2025 -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract...

TUESDAY, March 25, 2025 -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract...

New research reveals that women with ongoing urinary incontinence can skip invasive bladder pressure tests, as non-invasive assessments are just as...